Showing results (181-190 of 452) with videos related to
Sort By:
Pageof 46
Cancer|June 15, 2006
Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladderAtreya Dash, Matthew D Galsky, Andrew J Vickers, et al.The Journal of Urology|December 17, 2008
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteriaFernando P Secin, Fernando J Bianco, Angel Cronin, et al.Journal of Clinical Epidemiology|March 18, 2015
Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative GroupDaan Nieboer, Yvonne Vergouwe, Monique J Roobol, et al.The Journal of Urology|March 27, 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancerGanesh V Raj, Harry Herr, Angel M Serio, et al.The Journal of Urology|November 5, 2016
Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker PanelEric H Kim, Gerald L Andriole, E David Crawford, et al.The Journal of Urology|March 4, 2020
Prespecified 4-Kallikrein Marker Model at Age 50 or 60 for Early Detection of Lethal Prostate Cancer in a Large Population Based Cohort of Asymptomatic Men Followed for 20 YearsEmily A Vertosick, Christel Häggström, Daniel D Sjoberg, et al.Trials|February 28, 2012
Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomyAndrew J Vickers, Caroline Bennette, Karim Touijer, et al.Urologic Oncology|October 17, 2017
Concordance between patient-reported and physician-reported sexual function after radical prostatectomyAlan E Thong, Bing Ying Poon, Justin K Lee, et al.The Lancet. Oncology|April 4, 2009
The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort studyAndrew J Vickers, Caroline J Savage, Marcel Hruza, et al.Clinical Trials (London, England)|July 5, 2023
A randomized comparison of two-stage versus traditional one-stage consent for a low-stakes randomized trialAndrew J Vickers, Emily A Vertosick, Mia Austria, et al.Pageof 46